Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement

作者:John R. Greenland, Michael Perch, K. Halloran, Deborah J. Levine, Eric D. Morrell, A. Reed, Ciara M. Shaver, Jonathan P. Singer, Stuart C. Sweet, Robin Vos, Shambhu Aryal, Nicholas Avdimiretz, Fay Burrows, Daniel Calabrese, Fiorella Calabrese, Sílvia de Carvalho Campos, Michael Combs, Marc de Perrot, Göran Dellgren, Joshua M. Diamond, Thomas Egan, Patricia Ging, David V. Glidden, Martin Goddard, Soma Jyothula, Michael Keller, Hrishikesh S. Kulkarni, Johanna M. Kwakkel-van Erp, Vibha Lama, Nandor Marczin, Tereza Martinu, Megan L. Neely, Scott M. Palmer, Caroline Patterson, Elizabeth N. Pavlisko, Christine Pham, Melissa D. Sánchez, Hans Henrik L. Schultz, Nicolaus Schwerk, Unmil Shah, M.G.S. Shashaty, Lianne Singer, Patrick Smith, Laurie D. Snyder, Melinda Solomon, Stijn E. Verleden, Veronique Verplancke, Adriana Zeevi, Jamie L. Todd · 发表于:The Journal of Heart and Lung Transplantation · 年份:2026 · DOI:10.1016/j.healun.2025.09.016 · 被引用次数:2 · 研究领域:Transplantation: Methods and Outcomes、Renal Transplantation Outcomes and Treatments、Complement system in diseases